Results 201 to 210 of about 10,366,637 (362)
Characterising the dietary patterns of the European Roe Deer across biogeographical regions. [PDF]
Hirst C, Gill R, Ogden R, Shaw DJ.
europepmc +1 more source
Green Space Production as a State Project in Urban China
Short Abstract We examine the politics of developing Chengdu's greenway project by advancing the concept of state entrepreneurialism through strategic embeddedness and tactical mobilisation. We define strategic embeddedness as the institutional integration of market into the state apparatus to achieve the state's strategic goals and tactical ...
Handuo Deng, Fulong Wu, Fangzhu Zhang
wiley +1 more source
Impact of CDK4/6 inhibitors on health-related quality of life outcomes in patients with metastatic breast cancer: A systematic review and meta-analysis. [PDF]
Kiener T, Li KH, Chiang E, Le QA.
europepmc +1 more source
What's new? PARP inhibitors are effective in patients with inactivating alterations in the BRCA1/2 genes across tumor types. However, the efficacy of PARP inhibitors in patients with other inactivated homologous recombination repair genes remains unclear. This knowledge gap and discrepancies in EMA/FDA approvals highlight the need for better biomarkers.
Ilse A. C. Spiekman +15 more
wiley +1 more source
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as an Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE-2) in Patients With Predominant Negative Symptoms. [PDF]
Bugarski-Kirola D +3 more
europepmc +1 more source
Biliary PAH metabolites in European eel (Anguilla anguilla) from Mar Menor lagoon (SE Spain) [PDF]
Ángel Gea-Pacheco +4 more
openalex
What's new? New antibody‐drug conjugates (ADCs) and immunotherapies have helped expand treatment options for urothelial carcinoma (UC). Clinical trials suggest that the ADC enfortumab vedotin (EV) and the immunotherapeutic agent pembrolizumab, when used in combination, are especially effective against UC.
Dora Niedersuess‐Beke +30 more
wiley +1 more source

